Apobec Discovery
Develops small-molecule APOBEC enzyme inhibitors for cancer research and potential treatment
Highlights
- New on EvolcAdded 2026-11-14
About Apobec Discovery
Apobec Discovery is a preclinical research company developing selective small-molecule inhibitors of APOBEC enzymes, which drive mutations and treatment resistance in cancer.
The company was founded in 2018 and is headquartered in Cambridge, United Kingdom. Its leadership includes a CEO, chief scientific officer and board members with biotechnology, oncology and life-sciences experience.
Product: Preclinical development of selective small-molecule inhibitors targeting APOBEC enzymes in cancer.
Jobs at Apobec Discovery
More biotech & pharma companies
Apollo Scientific
Supplies research chemicals, life-science reagents and synthesis services to laboratories, researchers and manufacturersApollo Therapeutics
Portfolio biopharmaceutical company developing new medicines from university biomedical research and in-licensed clinical programsApterna
Preclinical biotech developing liver-directed RNA therapies to restore liver function for patients with liver cancerAqabela
Microbiome-based drinking water formulation for pharma partners developing treatments for chronic inflammatory and respiratory diseaseNew on EvolcArctorians
Automated drug discovery research and experimental data services for biotech, techbio and pharmaceutical companiesArecor
Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseases
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.